Cargando…
Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine
Adequate antipsychotic treatment intensity is required for defining treatment-resistant schizophrenia (TRS) and justifying clozapine treatment. We investigated the occurrence of undetectable or subtherapeutic serum levels of oral antipsychotics preceding switch to clozapine as an endpoint of TRS. Fo...
Autores principales: | Kyllesø, Lennart, Smith, Robert Løvsletten, Karlstad, Øystein, Andreassen, Ole A., Molden, Espen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367852/ https://www.ncbi.nlm.nih.gov/pubmed/32681055 http://dx.doi.org/10.1038/s41537-020-0107-7 |
Ejemplares similares
-
Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients
por: Kyllesø, Lennart, et al.
Publicado: (2021) -
Metabolite Profiling of Clozapine in Patients Switching Versus Maintaining Treatment: A Retrospective Pilot Study
por: Kyllesø, Lennart, et al.
Publicado: (2022) -
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits
por: Smith, Robert Løvsletten, et al.
Publicado: (2020) -
Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits
por: Lenk, Hasan Çağın, et al.
Publicado: (2022) -
Correction: Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients—a genome-wide association study adjusting for smoking habits
por: Smith, Robert Løvsletten, et al.
Publicado: (2020)